QurAlis Corp — Form D
QurAlis Corp of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-13. The offering totals $88.0M, of which $60.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-03-13
- Form: D
- Accession: 0001567619-23-004904
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $88.0M
- Amount sold: $60.0M
- Remaining: $28.0M
- Investors: 27
- Date of first sale: 2022-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-475621
Issuer
- Name: QurAlis Corp
- CIK: 0001811817
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 35 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MA, 02140
- Phone: 781-816-7031
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Hagen CD Cramer | Executive Officer | Cambridge, MA |
| Daniel CD Elbaum | Executive Officer | Cambridge, MA |
| Angela CD Genge | Executive Officer | Cambridge, MA |
| Vikas CD Sharma | Executive Officer | Cambridge, MA |
| Chris CD Thomajan | Executive Officer | Cambridge, MA |
| Julio E Vega | Executive Officer | Cambridge, MA |
| Laia CD Crespo-Martin | Director | Cambridge, MA |
| Shafique CD Virani | Executive Officer | Cambridge, MA |
| Johannes CD Fruehauf | Director | Cambridge, MA |
| Michael CD Hutton | Director | Cambridge, MA |
| Jason CD Brown | Executive Officer | Cambridge, MA |
| Anne CD Whitaker | Director | Cambridge, MA |
| Kasper CD Roet | Director | Cambridge, MA |
| Kasper CD Roet | Executive Officer | Cambridge, MA |
| Kasper CD Roet | Promoter | Cambridge, MA |
| Amy CD Schulman | Director | Cambridge, MA |
| Luc CD Dochez | Director | Cambridge, MA |
| Cillian CD King | Director | Cambridge, MA |
| Roel CD Bulthuis | Director | Cambridge, MA |
| Jonathan CD Behr | Director | Cambridge, MA |
| Jonathan CD Fleming | Director | Cambridge, MA |
Other filings by this issuer (3)
More